What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Acquired immunodeficiency syndrome
- Tuberculosis
His main research concerns Internal medicine, Immunology, Acquired immunodeficiency syndrome, Tuberculosis and Viral disease.
His Internal medicine research incorporates themes from Pyrazinamide, Surgery and Ethambutol.
His study in Immunology is interdisciplinary in nature, drawing from both Disease, Retrospective cohort study and Risk factor.
His Acquired immunodeficiency syndrome research is multidisciplinary, incorporating perspectives in Health care, Pharmacotherapy, Viral load and Cohort study.
His Tuberculosis research includes themes of Moxifloxacin and Chemoprophylaxis.
His Viral disease research integrates issues from Immunopathology and Pneumonia.
His most cited work include:
- Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study (2421 citations)
- Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. (491 citations)
- USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus (404 citations)
What are the main themes of his work throughout his whole career to date?
Richard E. Chaisson spends much of his time researching Tuberculosis, Internal medicine, Immunology, Acquired immunodeficiency syndrome and Surgery.
His work carried out in the field of Tuberculosis brings together such families of science as Incidence, Pediatrics and Disease.
His research in Internal medicine focuses on subjects like Pyrazinamide, which are connected to Ethambutol.
As part of the same scientific family, Richard E. Chaisson usually focuses on Immunology, concentrating on Regimen and intersecting with Intensive care medicine.
His study looks at the intersection of Acquired immunodeficiency syndrome and topics like Viral disease with Immunopathology.
The study incorporates disciplines such as Rifapentine, Latent tuberculosis and Chemoprophylaxis in addition to Isoniazid.
He most often published in these fields:
- Tuberculosis (53.33%)
- Internal medicine (48.05%)
- Immunology (35.86%)
What were the highlights of his more recent work (between 2014-2021)?
- Tuberculosis (53.33%)
- Internal medicine (48.05%)
- Rifapentine (5.06%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Tuberculosis, Internal medicine, Rifapentine, Isoniazid and Regimen.
The Tuberculosis study combines topics in areas such as Clinical trial, Randomized controlled trial, Intensive care medicine, Disease and Pediatrics.
His Internal medicine research focuses on Adverse effect in particular.
His work in Isoniazid covers topics such as Pharmacokinetics which are related to areas like Interquartile range and Efavirenz.
Viral load is a subfield of Immunology that Richard E. Chaisson investigates.
Many of his studies involve connections with topics such as Logistic regression and Immunology.
Between 2014 and 2021, his most popular works were:
- Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study (2421 citations)
- Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. (491 citations)
- Building a tuberculosis-free world: The Lancet Commission on tuberculosis (118 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Acquired immunodeficiency syndrome
- Disease
The scientist’s investigation covers issues in Tuberculosis, Internal medicine, Immunology, Disease and Mycobacterium tuberculosis.
The various areas that Richard E. Chaisson examines in his Tuberculosis study include Regimen, Cause of death, Obstetrics, Coinfection and Pharmacology.
He studies Internal medicine, namely Randomized controlled trial.
Richard E. Chaisson combines subjects such as Acute Retroviral Syndrome, Antiretroviral therapy and Scabies with his study of Immunology.
His research integrates issues of Tuberculosis diagnosis and Environmental health in his study of Disease.
The concepts of his Mycobacterium tuberculosis study are interwoven with issues in Increased risk, Acquired immunodeficiency syndrome, Transmission, Global health and Airborne disease.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
